ArticleESMO open2022

Corrigendum to 'Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study': [ESMO Open Volume 7, Issue 2, April 2022, 100466].

K Sinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.